Literature DB >> 12058327

Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis.

Mi-Jeong Ahn, Chul Young Kim, Ji Suk Lee, Tae Gyun Kim, Seung Hee Kim, Chong-Kyo Lee, Bo-Bin Lee, Cha-Gyun Shin, Hoon Huh, Jinwoong Kim.   

Abstract

The bioassay-directed isolation of Terminalia chebula fruits afforded four human immunodeficiency virus type 1 (HIV-1) integrase inhibitors, gallic acid ( 1) and three galloyl glucoses ( 2 - 4). In addition, four flavonol glycoside gallates ( 5 - 8) from Euphorbia pekinensis containing the galloyl moiety also showed the inhibitory activity at a level comparable to those of 2 - 4. By comparison with the activities of the compounds not bearing this moiety, it is proposed that the galloyl moiety plays a major role for inhibition against the 3'-processing of HIV-1 integrase of these compounds.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12058327     DOI: 10.1055/s-2002-32070

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.007


  26 in total

1.  Antiplasmodial activity of botanical extracts against Plasmodium falciparum.

Authors:  Asokan Bagavan; Abdul Abdul Rahuman; Chinnaperumal Kamaraj; Naveen Kumar Kaushik; Dinesh Mohanakrishnan; Dinkar Sahal
Journal:  Parasitol Res       Date:  2010-11-16       Impact factor: 2.289

2.  Radiation protection by Terminalia chebula: some mechanistic aspects.

Authors:  Nitin Motilal Gandhi; Cherupally Krishnan Krishnan Nair
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

Review 3.  The development of Terminalia chebula Retz. (Combretaceae) in clinical research.

Authors:  Anwesa Bag; Subir Kumar Bhattacharyya; Rabi Ranjan Chattopadhyay
Journal:  Asian Pac J Trop Biomed       Date:  2013-03

4.  Gallic acid decreases hepatitis C virus expression through its antioxidant capacity.

Authors:  Mayela Govea-Salas; Ana Maria Rivas-Estilla; Raul Rodríguez-Herrera; Sonia A Lozano-Sepúlveda; Cristobal N Aguilar-Gonzalez; Alejandro Zugasti-Cruz; Tanya B Salas-Villalobos; Jesus Antonio Morlett-Chávez
Journal:  Exp Ther Med       Date:  2015-12-08       Impact factor: 2.447

5.  Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread.

Authors:  Liang-Tzung Lin; Ting-Ying Chen; Chueh-Yao Chung; Ryan S Noyce; T Bruce Grindley; Craig McCormick; Ta-Chen Lin; Guey-Horng Wang; Chun-Ching Lin; Christopher D Richardson
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

Review 6.  Anti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose.

Authors:  Jinhui Zhang; Li Li; Sung-Hoon Kim; Ann E Hagerman; Junxuan Lü
Journal:  Pharm Res       Date:  2009-07-02       Impact factor: 4.200

7.  In vitro anti-HIV-1 activity of ethyl gallate.

Authors:  C Muddu Krishna; J N Kolla; S Asha; T Sravan Kumar Reddy
Journal:  Virusdisease       Date:  2019-12-16

8.  Anti-HIV-1 activity, protease inhibition and safety profile of extracts prepared from Rhus parviflora.

Authors:  Manoj Modi; Boskey Pancholi; Shweta Kulshrestha; Ajay Kumar Rawat; Swadesh Malhotra; Satish Gupta
Journal:  BMC Complement Altern Med       Date:  2013-07-04       Impact factor: 3.659

9.  Protective Mechanism of KIOM-4 in Streptozotocin-Induced Pancreatic β-Cells Damage Is Involved in the Inhibition of Endoplasmic Reticulum Stress.

Authors:  Rui Zhang; Jin Sook Kim; Kyoung Ah Kang; Mei Jing Piao; Ki Cheon Kim; Jin Won Hyun
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-16       Impact factor: 2.629

10.  KIOM-4 Protects against Oxidative Stress-Induced Mitochondrial Damage in Pancreatic β-cells via Its Antioxidant Effects.

Authors:  Kyoung Ah Kang; Jin Sook Kim; Rui Zhang; Mei Jing Piao; Young Hee Maeng; Mi Young Kang; In Kyung Lee; Bum Joon Kim; Jin Won Hyun
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-08       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.